查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826963

2025年全球OTC檢測市場報告

Over The Counter Or OTC Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，OTC檢測市場快速擴張，規模從2024年的241億美元成長到2025年的274.7億美元，複合年成長率為14.0%。預測期內的成長主要得益於智慧家庭醫療的興起、遠端患者監護的興起、門診診所的興起、行動醫療（ 行動醫療 ）解決方案的成長以及訂閱式服務的興起。

預計未來幾年，OTC 檢測市場將快速成長，到 2029 年將達到 459.6 億美元，複合年成長率為 13.7%。預測期內成長的主要促進因素包括感染疾病疫情的上升、愛滋病毒感染率的上升、遠端患者監護的增加、智慧型手機的普及以及醫療相關感染 (HAIS) 的上升。預測期內的主要趨勢包括數位健康整合、行動應用整合、綜合護理模式、人工智慧和機器學習整合以及遠端感染控制監控。

非處方 (OTC) 檢測是指消費者無需處方箋即可購買和使用的診斷檢測。這些檢測專為自我管理而設計，允許個人監測和評估自身健康狀況的各個方面，而無需就醫。

非處方藥 (OTC) 檢測的主要類型包括膽固醇監測、尿液分析、藥物濫用檢測、傳染病檢查、大便潛血試驗和血糖監測。膽固醇監測檢測可測量血液膽固醇和血脂水平，以評估心臟健康並幫助預防心血管疾病。這些檢測可應用於心臟病學、腫瘤學、血糖監測、懷孕和不孕症、感染疾病檢測以及毒理學等領域。這些檢測服務於各種終端用戶，包括醫院和診所、居家醫療機構和診斷實驗室。

2025 年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療保健提供者正努力應對進口手術器械、診斷影像系統以及注射器和導管等消耗品成本的上漲，其中許多產品的國內替代品有限。這些不斷上漲的成本使醫療保健預算捉襟見肘，導致一些醫療機構推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，造成供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供OTC測試市場統計數據，例如全球市場規模、區域佔有率、競爭對手的OTC測試市場佔有率、詳細的OTC測試細分市場、市場趨勢以及OTC測試行業的商機。本OTC測試市場研究報告對行業現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整展望。

未來五年13.7%的成長率預測比我們先前的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會增加從中國和德國進口的COVID-19快速試紙的成本，從而擾亂美國消費者的醫療服務，導致預防性篩檢減少和自付費用增加。由於互惠關稅以及不斷升級的貿易摩擦和貿易限制對全球經濟和貿易的負面影響，其影響也將更加廣泛。

慢性病盛行率的上升預計將推動非處方藥 (OTC) 檢測市場的成長。由於人口老化、不健康的生活方式、環境影響以及社會經濟差距等因素，持續一年以上且需要持續醫療照護的慢性病正變得越來越普遍。 OTC 檢測在慢性病管理中發揮關鍵作用，它能夠實現早期發現，幫助個人監測自身健康狀況，並促進及時干預，最終透過主動護理改善健康狀況。例如，美國國家生物技術資訊中心 (NCBI) 在 2023 年 1 月預測，到 2050 年，患有至少一種慢性病的 50 歲及以上人群數量將增加 99.5%，從 2020 年的 7,152.2 萬人增加到 1.4266 億人。日益加重的疾病負擔正在刺激對 OTC 診斷解決方案的需求。

非處方藥 (OTC) 檢測市場的主要企業正專注於開發家用檢測套組，以提高消費者的便利性、準確性和可及性。家用檢測套組可讓消費者在家中舒適地診斷某些健康狀況，並且通常可以透過血液、唾液或尿液樣本快速獲得結果。例如，2023 年 12 月，美國分子診斷公司 DiaCarta 的 iColon大便潛血試驗檢測 (FOBT) 獲得美國FDA 510(k) 批准，並獲得了 OTC核准。這項創新檢測有助於早期發現糞便潛血，而潛血是胃腸道疾病和大腸癌（全球第三大常見癌症）的關鍵指標。 iColon FOBT 與 DiaCarta 現有的 ColoScape 檢測相輔相成，進一步強化了其對早期癌症檢測和治療的承諾。

2024年12月，美國醫療設備製造商OraSure Technologies收購了Sherlock Biosciences，收購金額未揭露。此次策略收購旨在透過整合Sherlock先進的分子診斷平台，增強OraSure的診斷服務。該平台以一次性使用的形式提供快速且準確的結果，非常適合居家檢測。此次收購符合OraSure透過創新檢測解決方案改善醫療服務的可近性和可負擔性的更廣泛目標。總部位於美國的Sherlock Biosciences專注於非處方(OTC)一次性分子檢測，尤其性行為感染感染(STI)。

非處方藥 (OTC) 檢測市場包括血糖值儀、指尖採血膽固醇檢測套組、皮膚點刺過敏測試、血壓計等產品的銷售。該市場的價值是指“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球場外交易市場：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球OTC檢測市場：成長率分析
  • 全球OTC檢測市場表現：規模與成長，2019-2024年
  • 全球OTC檢測市場預測：規模與成長，2024-2029年，2034年
  • 全球非處方藥檢測：總潛在市場（TAM）

第6章 市場細分

  • 全球非處方藥檢測市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 膽固醇監測測試
  • 尿液檢查
  • 藥物濫用檢測
  • 傳染病檢查
  • 大便潛血試驗
  • 血糖監測測試
  • 全球OTC檢測市場：依應用、績效及預測，2019-2024年、2024-2029年、2034年
  • 心臟病學
  • 腫瘤學
  • 血糖監測
  • 懷孕和生育能力
  • 感染疾病
  • 毒理學
  • 全球非處方藥檢測市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 居家護理
  • 診斷實驗室
  • 其他最終用戶
  • 全球非處方藥檢測市場：細分：膽固醇監測測試（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 總膽固醇檢測
  • HDL（高密度脂蛋白）測試
  • LDL（低密度脂蛋白）測試
  • 三酸甘油酯檢測
  • 全球非處方藥檢測市場：依尿液檢查類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 尿液檢查棒測試
  • 尿液顯微鏡檢查
  • 尿液培養
  • 尿液妊娠試驗
  • 全球非處方藥檢測市場：依藥物濫用檢測類型細分、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 尿液藥物檢測
  • 唾液毒品測試
  • 毛髮藥物測試
  • 呼氣毒品測試
  • 全球非處方藥檢測市場：依傳染病檢查類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • HIV檢測
  • 肝炎檢測
  • 流感檢測
  • COVID-19檢測
  • 鏈球菌咽頭炎檢查
  • 全球非處方藥檢測市場：大便潛血試驗細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 癒創木脂大便潛血試驗（gFOBT）
  • 免疫化學大便潛血試驗（iFOBT/FIT）
  • 全球非處方藥檢測市場：依血糖監測檢測類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 血糖儀
  • 持續血糖監測（CGM）系統
  • 尿糖試紙

第7章 區域和國家分析

  • 全球OTC檢測市場：區域表現及預測（2019-2024年、2024-2029年及2034年）
  • 全球非處方藥檢測市場：依國家分類、實際及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • OTC檢測市場：競爭格局
  • OTC測試市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company（BD）Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • QuidelOrtho Corporation
  • Kroger Health
  • Dexcom Inc.
  • Bio-Rad Laboratories Inc.
  • SD Biosensor Inc.
  • OraSure Technologies Inc.
  • Everlywell Inc.
  • LetsGetChecked Inc.
  • Bionime Corporation
  • Nipro Diagnostics Inc.
  • Chembio Diagnostics Inc.
  • ACON Laboratories Inc.
  • iHealth Labs Inc.
  • Ellume Limited
  • Geratherm Medical AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年 OTC 檢測市場：提供新機會的國家
  • 2029 年 OTC 檢測市場：細分領域帶來新機會
  • 2029 年 OTC 檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r34107u

Over-the-counter (OTC) tests are diagnostic tests that consumers can purchase and use without a prescription. Designed for self-administration, these tests enable individuals to monitor or assess various aspects of their health without requiring a doctor's visit.

The primary types of OTC tests include cholesterol monitoring, urine analysis, drug abuse testing, infectious disease testing, fecal occult blood tests, and glucose monitoring. Cholesterol monitoring tests measure blood cholesterol and lipid levels to assess heart health and help prevent cardiovascular diseases. These tests are applied in cardiology, oncology, glucose monitoring, pregnancy and fertility, infectious disease detection, and toxicology. They serve various end users, including hospitals and clinics, home care settings, diagnostic laboratories, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The over the counter or OTC test market research report is one of a series of new reports from The Business Research Company that provides over the counter or OTC test market statistics, including the over the counter or OTC test industry global market size, regional shares, competitors with the over the counter or OTC test market share, detailed over the counter or OTC test market segments, market trends, and opportunities, and any further data you may need to thrive in the over the counter or OTC test industry. This over the counter or OTC test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The over the counter or otc test market size has grown rapidly in recent years. It will grow from $24.1 billion in 2024 to $27.47 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to the rise of smart home healthcare, rising remote patient monitoring, the rise of outpatient clinics, the growth of mHealth (mobile health) solutions, and the rise of subscription-based services.

The over the counter or otc test market size is expected to see rapid growth in the next few years. It will grow to $45.96 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to the increasing prevalence of infectious diseases, increasing number of HIV-infected, rising remote patient monitoring, increasing penetration of smartphones, and rising healthcare-associated infections (HAIS). Major trends in the forecast period include the integration of digital health, integration with mobile apps, integrated care models, the integration of AI and machine learning, and remote infection control monitoring.

The forecast of 13.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. consumer health access by increasing costs for rapid COVID-19 and cholesterol test strips imported from China and Germany, potentially leading to reduced preventive screening and higher out-of-pocket expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is expected to drive the growth of the over-the-counter (OTC) test market. Chronic diseases, which persist for a year or more and require ongoing medical attention, are becoming more widespread due to factors such as aging populations, unhealthy lifestyles, environmental influences, and socioeconomic disparities. OTC tests play a crucial role in managing chronic diseases by enabling early detection, empowering individuals to monitor their health, and facilitating timely interventions, ultimately improving health outcomes through proactive care. For example, in January 2023, the National Center for Biotechnology Information (NCBI) projected that by 2050, the number of individuals aged 50 years and older with at least one chronic illness will rise by 99.5%, from 71.522 million in 2020 to 142.66 million. This growing disease burden is fueling demand for OTC diagnostic solutions.

Leading companies in the OTC test market are focusing on advancing at-home test kits to improve convenience, accuracy, and accessibility for consumers. At-home test kits enable individuals to diagnose specific health conditions from the comfort of their homes, often providing rapid results from blood, saliva, or urine samples. For instance, in December 2023, DiaCarta, a US-based molecular diagnostics company, received OTC approval for its iColon Fecal Occult Blood Test (FOBT) following US FDA 510(k) clearance. This innovative test facilitates early detection of blood in stool, a key indicator of gastrointestinal disorders and colorectal cancer-the third most common cancer worldwide. The iColon FOBT complements DiaCarta's existing ColoScape Test, further strengthening the company's commitment to improving early cancer detection and intervention.

In December 2024, OraSure Technologies, a US-based medical device company, acquired Sherlock Biosciences for an undisclosed amount. This strategic acquisition aims to enhance OraSure's diagnostic offerings by integrating Sherlock's advanced molecular diagnostics platform, which provides fast, accurate results in a disposable format ideal for home testing. The deal aligns with OraSure's broader objective of increasing healthcare access and affordability through innovative testing solutions. Sherlock Biosciences, a US-based manufacturer, specializes in OTC disposable molecular tests, particularly for sexually transmitted infections (STIs).

Major players in the over the counter or OTC test market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson and Company (BD), QuidelOrtho Corporation, Kroger Health, Dexcom Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., OraSure Technologies Inc., Everlywell Inc., LetsGetChecked Inc., Bionime Corporation, Nipro Diagnostics Inc., Chembio Diagnostics Inc., ACON Laboratories Inc., iHealth Labs Inc., Ellume Limited, Geratherm Medical AG, Wondfo Biotech Co. Ltd., bioLytical Laboratories Inc., Watmind USA, First Check Diagnostics LLC.

North America was the largest region in the over the counter or OTC test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in over the counter or OTC test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the over the counter or OTC test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The over-the-counter (OTC) tests market consists of sales of blood glucose meters, fingerstick cholesterol test kits, skin prick allergy tests, and blood pressure monitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Over The Counter Or OTC Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on over the counter or otc test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for over the counter or otc test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The over the counter or otc test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Cholesterol Monitoring Test; Urine Analysis Test; Drug Abuse Test; Infectious Disease Testing; Fecal Occult Test; Glucose Monitoring Test
  • 2) By Application: Cardiology; Oncology; Glucose Monitoring; Pregnancy And Fertility; Infectious Disease; Toxicology
  • 3) By End-User: Hospital And Clinic; Home Care; Diagnostic Laboratory; Other End-Users
  • Subsegments:
  • 1) By Cholesterol Monitoring Test: Total Cholesterol Test; HDL (High-Density Lipoprotein) Test; LDL (Low-Density Lipoprotein) Test; Triglycerides Test
  • 2) By Urine Analysis Test: Urine Dipstick Test; Urine Microscopy Test; Urine Culture Test; Urine Pregnancy Test
  • 3) By Drug Abuse Test: Urine Drug Test; Saliva Drug Test; Hair Follicle Drug Test; Breath Drug Test
  • 4) By Infectious Disease Testing: HIV Test; Hepatitis Test; Influenza Test; COVID-19 Test; Strep Throat Test
  • 5) By Fecal Occult Test: Guaiac-Based Fecal Occult Blood Test (gFOBT); Immunochemical Fecal Occult Blood Test (iFOBT/FIT)
  • 6) By Glucose Monitoring Test: Blood Glucose Meters; Continuous Glucose Monitoring (CGM) Systems; Urine Glucose Test Strips
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Siemens Healthineers AG; Becton, Dickinson and Company (BD); QuidelOrtho Corporation; Kroger Health; Dexcom Inc.; Bio-Rad Laboratories Inc.; SD Biosensor Inc.; OraSure Technologies Inc.; Everlywell Inc.; LetsGetChecked Inc.; Bionime Corporation; Nipro Diagnostics Inc.; Chembio Diagnostics Inc.; ACON Laboratories Inc.; iHealth Labs Inc.; Ellume Limited; Geratherm Medical AG; Wondfo Biotech Co. Ltd.; bioLytical Laboratories Inc.; Watmind USA; First Check Diagnostics LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Over The Counter Or OTC Test Market Characteristics

3. Over The Counter Or OTC Test Market Trends And Strategies

4. Over The Counter Or OTC Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Over The Counter Or OTC Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Over The Counter Or OTC Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Over The Counter Or OTC Test Market Growth Rate Analysis
  • 5.4. Global Over The Counter Or OTC Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Over The Counter Or OTC Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Over The Counter Or OTC Test Total Addressable Market (TAM)

6. Over The Counter Or OTC Test Market Segmentation

  • 6.1. Global Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cholesterol Monitoring Test
  • Urine Analysis Test
  • Drug Abuse Test
  • Infectious Disease Testing
  • Fecal Occult Test
  • Glucose Monitoring Test
  • 6.2. Global Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiology
  • Oncology
  • Glucose Monitoring
  • Pregnancy And Fertility
  • Infectious Disease
  • Toxicology
  • 6.3. Global Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital And Clinic
  • Home Care
  • Diagnostic Laboratory
  • Other End-Users
  • 6.4. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Cholesterol Monitoring Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Total Cholesterol Test
  • HDL (High-Density Lipoprotein) Test
  • LDL (Low-Density Lipoprotein) Test
  • Triglycerides Test
  • 6.5. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Urine Analysis Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Dipstick Test
  • Urine Microscopy Test
  • Urine Culture Test
  • Urine Pregnancy Test
  • 6.6. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Drug Abuse Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Drug Test
  • Saliva Drug Test
  • Hair Follicle Drug Test
  • Breath Drug Test
  • 6.7. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Infectious Disease Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • HIV Test
  • Hepatitis Test
  • Influenza Test
  • COVID-19 Test
  • Strep Throat Test
  • 6.8. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Fecal Occult Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Guaiac-Based Fecal Occult Blood Test (gFOBT)
  • Immunochemical Fecal Occult Blood Test (iFOBT/FIT)
  • 6.9. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Glucose Monitoring Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Meters
  • Continuous Glucose Monitoring (CGM) Systems
  • Urine Glucose Test Strips

7. Over The Counter Or OTC Test Market Regional And Country Analysis

  • 7.1. Global Over The Counter Or OTC Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Over The Counter Or OTC Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Over The Counter Or OTC Test Market

  • 8.1. Asia-Pacific Over The Counter Or OTC Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Over The Counter Or OTC Test Market

  • 9.1. China Over The Counter Or OTC Test Market Overview
  • 9.2. China Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Over The Counter Or OTC Test Market

  • 10.1. India Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Over The Counter Or OTC Test Market

  • 11.1. Japan Over The Counter Or OTC Test Market Overview
  • 11.2. Japan Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Over The Counter Or OTC Test Market

  • 12.1. Australia Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Over The Counter Or OTC Test Market

  • 13.1. Indonesia Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Over The Counter Or OTC Test Market

  • 14.1. South Korea Over The Counter Or OTC Test Market Overview
  • 14.2. South Korea Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Over The Counter Or OTC Test Market

  • 15.1. Western Europe Over The Counter Or OTC Test Market Overview
  • 15.2. Western Europe Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Over The Counter Or OTC Test Market

  • 16.1. UK Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Over The Counter Or OTC Test Market

  • 17.1. Germany Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Over The Counter Or OTC Test Market

  • 18.1. France Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Over The Counter Or OTC Test Market

  • 19.1. Italy Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Over The Counter Or OTC Test Market

  • 20.1. Spain Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Over The Counter Or OTC Test Market

  • 21.1. Eastern Europe Over The Counter Or OTC Test Market Overview
  • 21.2. Eastern Europe Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Over The Counter Or OTC Test Market

  • 22.1. Russia Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Over The Counter Or OTC Test Market

  • 23.1. North America Over The Counter Or OTC Test Market Overview
  • 23.2. North America Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Over The Counter Or OTC Test Market

  • 24.1. USA Over The Counter Or OTC Test Market Overview
  • 24.2. USA Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Over The Counter Or OTC Test Market

  • 25.1. Canada Over The Counter Or OTC Test Market Overview
  • 25.2. Canada Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Over The Counter Or OTC Test Market

  • 26.1. South America Over The Counter Or OTC Test Market Overview
  • 26.2. South America Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Over The Counter Or OTC Test Market

  • 27.1. Brazil Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Over The Counter Or OTC Test Market

  • 28.1. Middle East Over The Counter Or OTC Test Market Overview
  • 28.2. Middle East Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Over The Counter Or OTC Test Market

  • 29.1. Africa Over The Counter Or OTC Test Market Overview
  • 29.2. Africa Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Over The Counter Or OTC Test Market Competitive Landscape And Company Profiles

  • 30.1. Over The Counter Or OTC Test Market Competitive Landscape
  • 30.2. Over The Counter Or OTC Test Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis

31. Over The Counter Or OTC Test Market Other Major And Innovative Companies

  • 31.1. QuidelOrtho Corporation
  • 31.2. Kroger Health
  • 31.3. Dexcom Inc.
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. SD Biosensor Inc.
  • 31.6. OraSure Technologies Inc.
  • 31.7. Everlywell Inc.
  • 31.8. LetsGetChecked Inc.
  • 31.9. Bionime Corporation
  • 31.10. Nipro Diagnostics Inc.
  • 31.11. Chembio Diagnostics Inc.
  • 31.12. ACON Laboratories Inc.
  • 31.13. iHealth Labs Inc.
  • 31.14. Ellume Limited
  • 31.15. Geratherm Medical AG

32. Global Over The Counter Or OTC Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Over The Counter Or OTC Test Market

34. Recent Developments In The Over The Counter Or OTC Test Market

35. Over The Counter Or OTC Test Market High Potential Countries, Segments and Strategies

  • 35.1 Over The Counter Or OTC Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Over The Counter Or OTC Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Over The Counter Or OTC Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer